Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2562 Views
-
Last post by NHE
-
- 0 Replies
- 365 Views
-
Last post by NHE
-
- 6 Replies
- 7557 Views
-
Last post by ElliotB
-
- 0 Replies
- 3793 Views
-
Last post by NHE
-
- 0 Replies
- 1422 Views
-
Last post by NHE
-
- 0 Replies
- 335 Views
-
Last post by NHE
-
- 0 Replies
- 3487 Views
-
Last post by NHE
-
- 11 Replies
- 3533 Views
-
Last post by NHE
-
- 1 Replies
- 1159 Views
-
Last post by NHE